| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/14/2010 | US20100008902 P450rai-2 (p450 cytochrome 26b), encoding nucleic acid molecules and methods and uses thereof |
| 01/14/2010 | US20100008901 Methods for the treatment and prevention of cancer |
| 01/14/2010 | US20100008896 Use of Fenretinide or Bioactive Derivatives Thereof and Pharmaceutical Compositions Comprising the Same |
| 01/14/2010 | US20100008888 Co-administration of cg250 and il-2 or ifn-alpha for treating cancer such as renal cell carcinomas |
| 01/14/2010 | US20100008855 Production and Use of Novel Peptide-Based Agents with Bispecific Antibodies |
| 01/14/2010 | US20100008852 Bi-specific monoclonal antibody (specific for both cd3 and cd11b) therapeutic drug |
| 01/14/2010 | DE10235602B4 Metallcluster-Nanoverbindungen zur Behandlung von Tumorerkrankungen Metal nano-cluster compounds for the treatment of tumor diseases |
| 01/14/2010 | CA2756053A1 Alpha-galactosyl ceramide analogs and their use as immunotherapies, adjuvants, and antiviral, antibacterial, and anticancer agents |
| 01/14/2010 | CA2743975A1 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 01/14/2010 | CA2734348A1 Glycopeptide constructs and uses thereof |
| 01/14/2010 | CA2730591A1 9-alpha estratriene derivatives as er-beta selective ligands for the prevention and treatment of intestinal cancer |
| 01/14/2010 | CA2730319A1 Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof |
| 01/14/2010 | CA2730314A1 Bicyclic compounds having antimitotic and/or antitumor activity and methods of use thereof |
| 01/14/2010 | CA2730311A1 Icotinib hydrochloride, synthesis, crystalline forms, drug combinations, and uses thereof |
| 01/14/2010 | CA2730308A1 Peptides and their use as carriers into cancer cells |
| 01/14/2010 | CA2730300A1 Fgf-r4 receptor-specific antagonists |
| 01/14/2010 | CA2730271A1 Pi3k isoform selective inhibitors |
| 01/14/2010 | CA2730270A1 Dicarba-analogues of octreotide |
| 01/14/2010 | CA2730257A1 2-methylene-19,26-dinor-(20s,22e,25r)-vitamin d analogs |
| 01/14/2010 | CA2730254A1 2-methylene-(17z)-17(20)-dehydro-19,21-dinor-vitamin d analogs |
| 01/14/2010 | CA2730251A1 Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 01/14/2010 | CA2730248A1 2-methylene-(20e)-20(22)-dehydro-19-nor-vitamin d analogs |
| 01/14/2010 | CA2730247A1 2-methylene-20(21)-dehydro-19-nor-vitamin d analogs |
| 01/14/2010 | CA2730244A1 2-methylene-19,26-dinor-(20r,22e,25r)-vitamin d analogs |
| 01/14/2010 | CA2730231A1 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 01/14/2010 | CA2730201A1 Pharmaceutical composition for treatment and prevention of cancer |
| 01/14/2010 | CA2730110A1 Combination of a c-met antagonist and an aminoheteroaryl compound for the treatment of cancer |
| 01/14/2010 | CA2730106A1 Kinase inhibitors and methods of use |
| 01/14/2010 | CA2730088A1 Immunity-inducing agent and method for detection of cancer |
| 01/14/2010 | CA2730085A1 Functional micelles for hard tissue targeted delivery of chemicals |
| 01/14/2010 | CA2730079A1 Processes for the preparation of crystalline forms of sunitinib malate |
| 01/14/2010 | CA2730071A1 Antineoplastic derivatives of 4-oxo-l, 4-dihydro-quinolin?, preparation thereof, and therapeutic use thereof |
| 01/14/2010 | CA2730010A1 Inhibitors of janus kinases |
| 01/14/2010 | CA2729988A1 Stat3 inhibitor containing quinolinecarboxamide derivative as active ingredient |
| 01/14/2010 | CA2729943A1 Novel inhibitors of proliferation and activation of signal transducer and activator of transcription (stats) |
| 01/14/2010 | CA2729896A1 Substituted 1-benzyl-cinnolin-4(1h)-one derivatives, preparation thereof, and therapeutic use thereof |
| 01/14/2010 | CA2729833A1 Pyridino-pyridinone derivatives, preparation thereof, and therapeutic use thereof |
| 01/14/2010 | CA2729633A1 Tumor-initiating cells and methods of use |
| 01/14/2010 | CA2729602A1 Notch1 receptor binding agents and methods of use thereof |
| 01/14/2010 | CA2729351A1 Fn14/trail fusion proteins |
| 01/14/2010 | CA2729306A1 Notch-binding agents and antagonists and methods of use thereof |
| 01/14/2010 | CA2728347A1 Lm-1 antibodies, functional fragments, lm-1 target antigen, and methods for making and using same |
| 01/14/2010 | CA2728344A1 Compositions for inducing immune responses specific to globo h and ssea3 and uses thereof in cancer treatment |
| 01/14/2010 | CA2728343A1 18f-labelled three- and four-carbon acids for pet imaging |
| 01/14/2010 | CA2727574A1 Multi-leu peptides and analogues thereof as selective pace4 inhibitors and effective antiproliferative agents |
| 01/14/2010 | CA2727388A1 Anti-tumor immunotherapy |
| 01/14/2010 | CA2727282A1 Novel pyrrolidine derivatives as metap-2 inhibitors |
| 01/13/2010 | EP2144065A1 HLA-E Binding |
| 01/13/2010 | EP2143795A2 Anti-CD20 monoclonal antibody |
| 01/13/2010 | EP2143794A1 Viral vector for gene therapy |
| 01/13/2010 | EP2143731A1 Compounds for immunotherapy of prostate cancer and methods for their use |
| 01/13/2010 | EP2143444A1 Compositions for inhibition of anglogenesis |
| 01/13/2010 | EP2143442A1 Treatment of solid tumors with tissue inhibitors of metalloproteinases(TIMPs) |
| 01/13/2010 | EP2143441A1 Combination of a c-Met antagonist and an aminoheteroaryl compound for the treatment of cancer |
| 01/13/2010 | EP2143438A1 Compositions and methods for the diagnosis and treatment of tumor |
| 01/13/2010 | EP2143437A1 Compositions and methods for the diagnosis and treatment of tumor |
| 01/13/2010 | EP2143432A1 9-alpha estratriene derivatives as ER-beta selective ligands for the prevention and treatment of intestinal cancer |
| 01/13/2010 | EP2143428A1 Tamibarotene capsule preparation |
| 01/13/2010 | EP2143424A1 Oral pharmaceutical preparation for colon-specific delivery |
| 01/13/2010 | EP2142669A2 Sirtuin based methods and compositions for treating b- catenin-related conditions |
| 01/13/2010 | EP2142569A2 Non-fucosylated antibodies |
| 01/13/2010 | EP2142568A1 Antibodies that bind both il-17a and il-17f and methods of using the same |
| 01/13/2010 | EP2142567A2 The ed-a antigen of fibrinogen is associated with the neovasculature of tumour metastases |
| 01/13/2010 | EP2142544A1 Pyrido [2, 3-d]pyrimidin-7-one compounds as inhibitors of pi3k-alpha for the treatment of cancer |
| 01/13/2010 | EP2142543A1 Pyrido [2, 3-d]pyrimidin-7-one compounds as inhibitors of pi3k-alpha for the treatment of cancer |
| 01/13/2010 | EP2142535A2 3-imidazolyl-indoles for the treatment of proliferative diseases |
| 01/13/2010 | EP2142531A1 Benzimidazole cannabinoid agonists |
| 01/13/2010 | EP2142518A1 3,4-dihydroquinazoline derivatives |
| 01/13/2010 | EP2142505A1 Sulfonamides and pharmaceutical compositions thereof |
| 01/13/2010 | EP2141994A1 Multi-ring compounds and uses thereof |
| 01/13/2010 | EP2035385B1 Inhibitors of akt (protein kinase b) |
| 01/13/2010 | EP1660095B1 Tricyclic parp inhibitors |
| 01/13/2010 | EP1499886B1 Methods and compositions for inducing an immune response |
| 01/13/2010 | EP1465886B1 Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 01/13/2010 | EP1406910B1 Preparation methods of derivatives of bisphosphonates |
| 01/13/2010 | EP1394253B1 Anti-human ovarian cancer -anti-cd3 bispecific antibody |
| 01/13/2010 | EP1360500B1 Methods for selective targeting |
| 01/13/2010 | EP1305322B1 Derivatives of branched-chain lipophilic molecules and uses thereof |
| 01/13/2010 | EP1255725B1 5-aminolevulinic acid formulation dissolved/dispersed in non-aqueous solvents |
| 01/13/2010 | EP1144388B1 Acyl derivatives which treat vla-4 related disorders |
| 01/13/2010 | CN100580085C Adenovirus/alpha virus hybrid vector for the effective administration and expression of therapeutic genes in tumour cells |
| 01/13/2010 | CN100580080C Corona-virus-like particles comprising functionally deleted genomes |
| 01/13/2010 | CN100579989C Interfusion protein between diphtheria toxin and GM-CSF mutant, coded gene and application |
| 01/13/2010 | CN100579988C Interfusion protein between diphtheria toxin and GM-CSF mutant, coded gene and application |
| 01/13/2010 | CN100579980C Ru(II) complex with anticancer liveness and method for preparing the same |
| 01/13/2010 | CN100579582C Combined use of enzyme inhibitors and pharmaceutical preparations thereof for the preparation of medicament for treatment and prophylaxis of arteriosclerosis, for the treatment and prevention of aller |
| 01/13/2010 | CN100579577C Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs |
| 01/13/2010 | CN100579536C Preparation method for graininess medicine containing hirsutella hepia - cordyceps fungus powder |
| 01/13/2010 | CN100579535C Improvements in or relating to immune functions |
| 01/13/2010 | CN100579527C Compositions comprising immunomodulatory compounds for the treatment and management of myelodysplastic syndromes and use method thereof |
| 01/13/2010 | CN100579523C Dihydroartemisinin emulsion for injection, freeze-dried emulsion and preparation method thereof |
| 01/13/2010 | CN100579512C Method of producing water-solubility hypocrellin titanium dioxide nano granule |
| 01/12/2010 | US7645788 Treating breast cancer cells which are both estrogen-dependent and estrogen-negative; chemical systhesis by reacting indole-3-carbinol with an oxidizing agent in a solvent, cyclization, purification |
| 01/12/2010 | US7645782 Ethyl (2Z,5S,6E)-5-(tert-Butyl-dimethyl-silanyloxy)-2,6-dimethyl-7-(2-methyl-1,3-thiazol-4-yl)-hepta-2,6-dienoate; (3S)-3-(tert-Butyl-dimethyl-silanyloxy)-tetrahydrofuranone; breast , epidermoid, ovarian, lung, prostate cancer, cervix carcinoma, cancer of the bladder or leukemia |
| 01/12/2010 | US7645779 Linked biaryl compounds |
| 01/12/2010 | US7645774 Sulfonamide-containing benzene derivatives; cancer and inflammatory, immunomodulatory or respiratory diseases; allergy, seasonal allergic rhinitis, reversible airway obstruction, adult respiratory distress syndrome, asthma, or bronchitis |
| 01/12/2010 | US7645768 Production of polyketides and other natural products |
| 01/12/2010 | US7645764 Kinase inhibitors and methods for using the same |
| 01/12/2010 | US7645762 Substituted pyrazolo[1,5-a] pyrimidines as protein kinase inhibitors |
| 01/12/2010 | US7645761 Indoline derivatives |